Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 15, 2010
False-positive results in the randomized controlled trial of mammographic screening from age 40 ("Age" trial)Louise E Johns, Sue M Moss, Breast Cancer Research : BCR|December 1, 2012
Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United KingdomNecdet B Gunsoy, Montserrat Garcia-Closas, Sue M MossJournal of Medical Screening|November 8, 2013
Screening and primary prevention of colorectal cancer: a review of sex-specific and site-specific differencesNathalie J Massat, Sue M Moss, Stephen P Halloran, et al.Lancet (London, England)|December 13, 2006
Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trialSue M Moss, Howard Cuckle, Andy Evans, et al.Breast Cancer Research : BCR|June 4, 2009
The spatial distribution of radiodense breast tissue: a longitudinal studySnehal M Pinto Pereira, Valerie A McCormack, Sue M Moss, et al.The Lancet. Oncology|July 25, 2015
Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trialSue M Moss, Christopher Wale, Robert Smith, et al.British Journal of Cancer|June 26, 2026
Long-term effectiveness and overdiagnosis in the NHS breast screening programme: a cohort study with up to 33 years of follow-upAmanda Dibden, Dharmishta Parmar, Rhian Gabe, et al.Epidemiology (Cambridge, Mass.)|March 14, 2015
Case-control Studies on the Effectiveness of Breast Cancer Screening: Insights from the UK Age TrialDaniëlle van der Waal, Mireille J M Broeders, André L M Verbeek, et al.BMC Cancer|February 11, 2010
Mammographic density and markers of socioeconomic status: a cross-sectional studyZoe Aitken, Kate Walker, Bernardine H Stegeman, et al.Journal of Medical Screening|August 12, 2016
Design-corrected variation by centre in mortality reduction in the ERSPC randomised prostate cancer screening trialMatti Hakama, Sue M Moss, Ulf-Hakan Stenman, et al.Pageof 4